Blog

Anheuser-Busch InBev SA/NV BUD, alias AB InBev, has been keen on making investments to drive overall growth. The company has been investing in developing a diverse portfolio of global

Earnings season is starting to slow now that we’ve heard from the majority of the S&P 500 and 6 out of the 7 Magnificent 7 stocks.

But many key consumer-focused companies are going to report

Xenon Pharmaceuticals XENE reported a loss of 83 cents per share for the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 94 cents. The company had incurred a loss of

American Public Education, Inc. APEI reported impressive first-quarter 2025 results, wherein adjusted earnings and total revenues topped the Zacks Consensus Estimate and grew year over year.The

The biggest hurdle facing Wall Street has abated as of now with the U.S.-China temporary trade truce. The United States has agreed to temporarily slash tariffs on Chinese goods from 145% to 30%

Landsea Homes Corporation LSEA reported lackluster first-quarter 2025 results, wherein adjusted earnings and total revenues missed the Zacks Consensus Estimate. On a year-over-year basis, the bottom

In line with its environment-friendly approach, United Airlines UAL recently announced an investment in Twelve, an innovative low-carbon fuels company. Twelve makes use of a process that is similar

MAG Silver (MAG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Jakks Pacific (JAKK) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Abacus Life, Inc. (ABL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Investors might want to bet on Insteel Industries (IIIN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Investors might want to bet on Caribou Biosciences, Inc. (CRBU), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Investors might want to bet on Community Financial System (CBU), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Investors might want to bet on Centerra Gold Inc. (CGAU), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Immunome, Inc. (IMNM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Saratoga Investment (SAR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which